Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma, Squamous Cell × Radiotherapy, Intensity-Modulated × Clear all

Phase

Phase 2 15 Phase NA 3 Phase 1/2 2 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 14 Head and Neck Neoplasms 11 Glioblastoma 8 Prostatic Neoplasms 7 Carcinoma 6 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Gliosarcoma 5 Carcinoma, Non-Small-Cell Lung 5 Astrocytoma 5 Neoplasm Metastasis 4 Uterine Cervical Neoplasms 3 Neoplasms 3 Glioma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oligodendroglioma 2 Medulloblastoma 2 Lymphoma, Follicular 2 Lymphoma 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Cisplatin 17 pembrolizumab 12 Radiotherapy 11 Nivolumab 7 Cetuximab 6 Paclitaxel 5 fludarabine 4 aldesleukin 4 Radiation 4 Interleukin-2 4 Docetaxel 4 Cyclophosphamide 4 olaparib 3 fludarabine phosphate 3 Carboplatin 3 talimogene laherparepvec 2 atezolizumab 2 Taxes 2 Sorafenib 2 Fluorouracil 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Capecitabine 2 Bortezomib 2 130-nm albumin-bound paclitaxel 2 vandetanib 1 tozuleristide 1 tilsotolimod 1 testosterone enanthate 1 temoporfin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01491139 2012-05-30

ORCA

University College, London

Phase 1 Withdrawn

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡